Deconstructing the complexity: Tailored Sample to Insight tools that put your data into action
Cancer is a highly complex disease and understanding the various alterations that together determine disease onset, progression, recurrence and response to treatment, is of fundamental importance. Deep understanding of the biological mechanisms is needed to deconstruct cancer’s underlying complexity.
Relevant biomarkers can be used as landmarks for navigating this biological complexity anchoring targeted treatment programs. Critical to program success are highly sensitive and specific assays that have tailored data analysis and interpretation. So the comprehensive biomarker profiling studies are an accurate foundation for actionable real-world insights.
To reserve a seat, use our registration form.
12:30 – 12:40 p.m.
Introduction to Speakers and QIAGEN Cancer Toolbox
Sheryl Elkin CSO, N-of-One
12:40 – 1:00 p.m.
Implementation of a comprehensive NGS Oncology Panel including MSI and TMB signatures
Ravindra Kolhe, MD, PhD, University of Augusta
1:00 – 1:15 p.m.
An unusual tumor evolution and a rare sarcoma: genomic analysis of gynecologic cancer cases using QIAGEN bioinformatic solutions to advance patient care
John A. Martignetti, MD PhD, Mount Sinai Hospital, New York City
1:15 – 1:30 p.m.
Understanding innate resistance to anti-PD1 in melanoma with Ingenuity Pathway Analysis (IPA) and OmicSoft
Jean-Noel Billaud PhD, QIAGEN